Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1998 Dec;74(878):729–732. doi: 10.1136/pgmj.74.878.729

Management of the unexpected result: compensated hypothyroidism.

R Benediktsson 1, A D Toft 1
PMCID: PMC2431636  PMID: 10320887

Abstract

The combination of elevated serum thyrotropin and normal serum thyroxine is called compensated or subclinical hypothyroidism. This most commonly represents clinically silent autoimmune thyroiditis. Whether this condition warrants treatment or simply observation is still debated. The risk of developing overt hypothyroidism is high in females with elevated thyrotropin above 10 mU/l and/or positive thyroid microsomal antibodies. Males are also at high risk of progression towards overt hypothyroidism, regardless of antibody status or degree of thyrotropin elevation. We advise routine treatment of only those at high risk of developing overt hypothyroidism.

Full text

PDF
729

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bagchi N., Brown T. R., Parish R. F. Thyroid dysfunction in adults over age 55 years. A study in an urban US community. Arch Intern Med. 1990 Apr;150(4):785–787. [PubMed] [Google Scholar]
  2. Carr D., McLeod D. T., Parry G., Thornes H. M. Fine adjustment of thyroxine replacement dosage: comparison of the thyrotrophin releasing hormone test using a sensitive thyrotrophin assay with measurement of free thyroid hormones and clinical assessment. Clin Endocrinol (Oxf) 1988 Mar;28(3):325–333. doi: 10.1111/j.1365-2265.1988.tb01219.x. [DOI] [PubMed] [Google Scholar]
  3. Cooper D. S., Halpern R., Wood L. C., Levin A. A., Ridgway E. C. L-Thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial. Ann Intern Med. 1984 Jul;101(1):18–24. doi: 10.7326/0003-4819-101-1-18. [DOI] [PubMed] [Google Scholar]
  4. Davies P. H., Franklyn J. A., Daykin J., Sheppard M. C. The significance of TSH values measured in a sensitive assay in the follow-up of hyperthyroid patients treated with radioiodine. J Clin Endocrinol Metab. 1992 May;74(5):1189–1194. doi: 10.1210/jcem.74.5.1569166. [DOI] [PubMed] [Google Scholar]
  5. Haggerty J. J., Jr, Garbutt J. C., Evans D. L., Golden R. N., Pedersen C., Simon J. S., Nemeroff C. B. Subclinical hypothyroidism: a review of neuropsychiatric aspects. Int J Psychiatry Med. 1990;20(2):193–208. doi: 10.2190/ADLY-1UU0-1A8L-HPXY. [DOI] [PubMed] [Google Scholar]
  6. Jansson S., Berg G., Lindstedt G., Michanek A., Nyström E. Overweight--a common problem among women treated for hyperthyroidism. Postgrad Med J. 1993 Feb;69(808):107–111. doi: 10.1136/pgmj.69.808.107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Joffe R. T., Levitt A. J. Major depression and subclinical (grade 2) hypothyroidism. Psychoneuroendocrinology. 1992 May-Jul;17(2-3):215–221. doi: 10.1016/0306-4530(92)90060-k. [DOI] [PubMed] [Google Scholar]
  8. Kabadi U. M., Cech R. Normal thyroxine and elevated thyrotropin concentrations: evolving hypothyroidism or persistent euthyroidism with reset thyrostat. J Endocrinol Invest. 1997 Jun;20(6):319–326. doi: 10.1007/BF03350310. [DOI] [PubMed] [Google Scholar]
  9. Laurberg P., Pedersen K. M., Hreidarsson A., Sigfusson N., Iversen E., Knudsen P. R. Iodine intake and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. J Clin Endocrinol Metab. 1998 Mar;83(3):765–769. doi: 10.1210/jcem.83.3.4624. [DOI] [PubMed] [Google Scholar]
  10. Lazarus J. H., Burr M. L., McGregor A. M., Weetman A. P., Ludgate M., Woodhead J. S., Hall R. The prevalence and progression of autoimmune thyroid disease in the elderly. Acta Endocrinol (Copenh) 1984 Jun;106(2):199–202. doi: 10.1530/acta.0.1060199. [DOI] [PubMed] [Google Scholar]
  11. Mariotti S., Sansoni P., Barbesino G., Caturegli P., Monti D., Cossarizza A., Giacomelli T., Passeri G., Fagiolo U., Pinchera A. Thyroid and other organ-specific autoantibodies in healthy centenarians. Lancet. 1992 Jun 20;339(8808):1506–1508. doi: 10.1016/0140-6736(92)91265-a. [DOI] [PubMed] [Google Scholar]
  12. Monzani F., Caraccio N., Siciliano G., Manca L., Murri L., Ferrannini E. Clinical and biochemical features of muscle dysfunction in subclinical hypothyroidism. J Clin Endocrinol Metab. 1997 Oct;82(10):3315–3318. doi: 10.1210/jcem.82.10.4296. [DOI] [PubMed] [Google Scholar]
  13. Nyström E., Caidahl K., Fager G., Wikkelsö C., Lundberg P. A., Lindstedt G. A double-blind cross-over 12-month study of L-thyroxine treatment of women with 'subclinical' hypothyroidism. Clin Endocrinol (Oxf) 1988 Jul;29(1):63–75. doi: 10.1111/j.1365-2265.1988.tb00250.x. [DOI] [PubMed] [Google Scholar]
  14. Okayasu I., Hara Y., Nakamura K., Rose N. R. Racial and age-related differences in incidence and severity of focal autoimmune thyroiditis. Am J Clin Pathol. 1994 Jun;101(6):698–702. doi: 10.1093/ajcp/101.6.698. [DOI] [PubMed] [Google Scholar]
  15. Parle J. V., Franklyn J. A., Cross K. W., Jones S. C., Sheppard M. C. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf) 1991 Jan;34(1):77–83. doi: 10.1111/j.1365-2265.1991.tb01739.x. [DOI] [PubMed] [Google Scholar]
  16. Ridgway E. C., Cooper D. S., Walker H., Rodbard D., Maloof F. Peripheral responses to thyroid hormone before and after L-thyroxine therapy in patients with subclinical hypothyroidism. J Clin Endocrinol Metab. 1981 Dec;53(6):1238–1242. doi: 10.1210/jcem-53-6-1238. [DOI] [PubMed] [Google Scholar]
  17. Sawin C. T., Castelli W. P., Hershman J. M., McNamara P., Bacharach P. The aging thyroid. Thyroid deficiency in the Framingham Study. Arch Intern Med. 1985 Aug;145(8):1386–1388. [PubMed] [Google Scholar]
  18. Sawin C. T., Geller A., Wolf P. A., Belanger A. J., Baker E., Bacharach P., Wilson P. W., Benjamin E. J., D'Agostino R. B. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994 Nov 10;331(19):1249–1252. doi: 10.1056/NEJM199411103311901. [DOI] [PubMed] [Google Scholar]
  19. Szabolcs I., Podoba J., Feldkamp J., Dohan O., Farkas I., Sajgó M., Takáts K. I., Góth M., Kovács L., Kressinszky K. Comparative screening for thyroid disorders in old age in areas of iodine deficiency, long-term iodine prophylaxis and abundant iodine intake. Clin Endocrinol (Oxf) 1997 Jul;47(1):87–92. doi: 10.1046/j.1365-2265.1997.2271040.x. [DOI] [PubMed] [Google Scholar]
  20. Tanis B. C., Westendorp G. J., Smelt H. M. Effect of thyroid substitution on hypercholesterolaemia in patients with subclinical hypothyroidism: a reanalysis of intervention studies. Clin Endocrinol (Oxf) 1996 Jun;44(6):643–649. doi: 10.1046/j.1365-2265.1996.739560.x. [DOI] [PubMed] [Google Scholar]
  21. Thyroxine replacement therapy. Lancet. 1991 Jan 19;337(8734):171–172. [PubMed] [Google Scholar]
  22. Tunbridge W. M., Evered D. C., Hall R., Appleton D., Brewis M., Clark F., Evans J. G., Young E., Bird T., Smith P. A. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977 Dec;7(6):481–493. doi: 10.1111/j.1365-2265.1977.tb01340.x. [DOI] [PubMed] [Google Scholar]
  23. Vanderpump M. P., Tunbridge W. M., French J. M., Appleton D., Bates D., Clark F., Grimley Evans J., Hasan D. M., Rodgers H., Tunbridge F. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995 Jul;43(1):55–68. doi: 10.1111/j.1365-2265.1995.tb01894.x. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES